ABSTRACT. Human fetal antibody-dependent cellular cytotosicity (ADCC) has not beer1 reported previously. hlost investigations have failed to document any cytolptic activity among fetal lymphocytes. The purpose of this study was to investigate ADCC activity in the human fetus and identify and characterize the effector cell populations in the fetus. Fetal spleen cells were separated into single-cell suspensions and assayed with "Cr-labeled herpes simples I-infected Chang liver target cells. Significant ADCC activity was detected in 19 of 26 (73%) of freshly assayed fetal spleen cell preparations from fetuses of 17-24 wk gestational age. This activity, however, was significantly less than concurrently run adult peripheral blood mononuclear cells. After plastic adherence the fetal spleen ADCC activity from nonadherent cells was not significantly different from whole spleen preparations. Surprisingly, ADCC activity in nonadherent fetal cells dropped significantly after exposure to lates beads, an effect not seen in nonadherent adult lymphocytes. Thus, either fetal monocyte-derived (macrophages) fetal spleen cells do not efficiently adhere to plastic or a unique nonadherent population of lates-sensitive imniunocytes is capable of mediating ADCC activity in the fetus. \Ve suspect the former conclusion to be the more plausible; however, fluorescence-activated cell sorter staining of fetal cells was not sufficient to confirm these suspensions by fluorescence-activated cell sorter analysis. In particular, there is very little demonstrated capacity for cellmediated cytotoxicity among fetal immunocytes in midtrimester. Most information has been derived from umbilical cord blood samples after delivery. Cell-mediated Iympholysis (CML) has becn described in peripheral blood of human fetuses of 18-2 1 wk gestation. but no such activity was detected in fetal thymus or spleen cells (2) (3) (4) . No studies have been published that specifically address the issue of ADCC during fetal life.
The active transport of maternal IgG across the human placenta is presumed t o play an important role in fctal immune protection: ADCC activity could be an important defense in situations in which the fetus is exposed to foreign antigens. such as HSV. that infect cells. ADCC is known to play an important role in the immune response to HSV infection in neonates after delivery (5) . The present study was designed to determine the extent of fetal ADCC activity against HSV-infected cells and the cfTector cell populations responsible for such activity.
MATERIALS AND METliODS
Fetal spl~cw ccfls. Whole spleens were obtained from 23 normal human fetuses after elective pregnancy termination bctween 17 and 24 wk gestational age. Spleens were immediately minced and passed through a fine wire-mesh filter, washed in HBSS and subjected to Ficoll-Hypaque differential centrifugation. The mononuclear cell layer was then rcmoved, washed three times in HBSS, and resuspended in minimum essential medium with Earle's salts containing 0.05 U/L penicillin, 50 g/L streptomycin, 2 m M glutamine, and 10% heat-inactivated fetal bovine serum (Hyclone Laboratories, Logan, UT) for use as effector cells.
Iiunratl Approximately 5 x 10h FSMC or adult PBMC tvere plated in 5 mL HBSS and incubated for 1 to 2 h at 37°C in 95% air. 5% C 0 2 . After incubation, the nonadherent population was removed and the plate washed three times with f1BSS. The cells were pelleted and resuspended in minimum essential medium. Cell counts were determined and viability verified by trypan blue exclusion. ADCC assays were performed as described below.
Addition of unfortn laresparticles. For all assays involving the use of uniform latex particles, I. 1-pm diameter (Dow Chemical Co., Indianapolis, IN), the individual cell suspensions were obtained and treated as described above. The target cells (lo3 cells/ well), the effector cells (whole cell, nonadherent cell, and adherent cell suspensions at 5 x lo4 cell/well), and latex particles ( I 0 pL) were added to the assay plate and incubated for I h at 37°C in 95% air, 5% C02. Control plates (effectors, targets, and 10 pL media) were also plated and incubated for I h at 37°C. After the I-h incubation, HSV I-positive sera, HSV I-negative sera, or media were added to appropriate wells. Plates were then incubated for 18 h (37"C, 5% C02) and harvested as described.
Virus and targel cells. The HE strain of HSV 1 was originally isolated in the laboratory of Dr. A. J. Nahimias (Emory University, Atlanta, GA). It was propagated in human Chang liver cells using minimum essential medium with Earle's salts containing 0.05 U/L penicillin, 50 g/L streptomycin, 2 mM glutamine, and 10% heat-inactivated fetal bovine serum.
Sera. Human blood was obtained aseptically from volunteer donors. After the blood clotted overnight at 4"C, serum was removed, centrifuged at 200 x gfor 10 min at room temperature, and inactivated at 50°C for 30 min. All sera were characterized as HSV antibody-positive or -negative by ELISA, Western blot, neutralization, and ADCC assay with known human standards. The HSV-positive sample was characterized as being HSV I+/ HSV2-in the laboratory of Dr. Ann Arvin (Department of Pediatrics, Stanford University School of Medicine, Palo Alto, CA) with an HSV 2 specific IgG ELISA.
ADCC assay. As previously described in detail, ADCC was determined with HE strain HSV I-infected "Cr-labeled Chang liver target cells approximately 24 h after infection (6) (7) (8) . Effector cells were added to target cells to a final volume of 0.2 mL in 96-well round-bottom microtiter plates (Coming Glass Works. Coming, NY). Fetal spleen cells were used at an optimal effectorto-target cell ratio of 50:l as determined by titration curve. Optimal antibody dilution was determined to be 100: 1 by antibody titration curve. Effector cells consisted of human fetal spleen cells or adult peripheral blood cells prepared as described above. Serum known to be positive or negative for anti-HSV antibody was diluted in media and added to wells to achieve a final dilution of 1:100. Assays were harvested after an 18-h incubation at 37°C in 5% C02-enriched air by aspirating 100 pL from the top of each well without disturbing the cell pellet. To each well, 100 pL of NaOH was added and the total remaining volume aspirated into a separate container. Each sample was counted in a Beckman 4000 gamma counter for 1 min (Beckman Instruments, Fullerton, CA). "Cr release was calculated according to the following formula:
A + B where A = cpm in top 100 pL and B = cpm in the pellet to which NaOH was added. ADCC was calculated as follows: In this assay system, more than 10% ADCC is significant (7, 8) .
Immunojluorescence staining of cell surjuces. Fetal spleen cell preparations and adult PBMC were prepared as described. After isolation, cells were suspended in staining media (RPMI 1640 + 3% FCS = 10 mM N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid + 0.1 % sodium azide). Cells were counted and viability confirmed by trypan exclusion. FMSC or PBMC were incubated with the manufacturer's suggested concentration of fluorochrome-conjugated anti-CD,, Leu-M I, anti-CD16, or anti-CD56 (NKH-I) MAb (Becton Dickinson, Palo Alto, CA). All incubations were performed for 20 min at 2-8°C in the dark. After incubation, cells were washed three times with cold staining media and fixed in 2% formaldehyde. Stained cells were kept refrigerated and protected from light until analyzed.
FACS atlaljsis. Single-and dual-color immunocytometry was performed on the FACS 440 (Becton Dickinson). Ten thousand events were collected and analyzed using FACSIDESK software (version 1.9).
Srurislicul atlulj.sis. Data are expressed as the mean + SD.
Differences
Ethical cotuidc~rutions. All specimens were obtained after appropriate informed consent and within the guidelines set forth by the University of California, San Francisco Committee on Human Research (IRB). This research did not fall under the moratorium of the Department of Health and Human Services because no therapeutic transplantation of fetal tissue was involved.
RESULTS
FShfC rcrslrs adtilt PB,\fC. ADCC activity in this assay system was considered significant if it was more than 10% above baseline activity with control (antibody-negative) serum. Significant ADCC activity was detected in 19 of 26 (73%) FSMC preparations of 17-24 wk gestation. ADCC data comparing the means of 19 separate fetal spleen cell preparations with significant activity and PBMC preparations is shown in Figure 1 ( p < 0.01), n = 6, after exposure to latex beads as shown in Figure 3 . No such effect was found in nonadherent adult PBMC (39.3 f 5. 1%) after exposure to latex beads (45.7 2 1 1.7%, p = 0.27), also shown in Figure 3 . Thus, a latex-sensitive, nonadherent cell population capable of ADCC activity was present in fetal spleen cell preparations that is not found in similarly treated adult lymphocyte populations. When whole cell populations (FSMC and PBMC) were tested before adherence and macrophage removal of adult cells, a significant drop in ADCC activity could be seen in both the FSMC and the PBMC after exposure to latex beads (Fig. 4) .
FACS. Among fetal cells derived from ADCC active whole spleen preparations, 36% (tt = 13) were CD,(+), 12.4% ((1 = 13) were C D I 6 (Leul I)-positive, and 8.4% (n = 11) were CDJ6 (Leul9)-positive. Among the ADCC active nonadherent fetal spleen cell preparations, 3 1 % (tz = 8) were CD,(+), 6.8% (tt = 8) were CD16(+), and 10.4% (n = 8) were CDJ6(+). No significant differences were observed between whole spleen cell preparations and nonadherent cells. Adherent cell populations were too few in recoverable numbers for FACS staining. although some capacity for natural killer cell cytotoxicity exists, n o allogeneic or antibody-dependent cellular cytotoxicity has been demonstrated. This demonstration has been limited to a few reports on cell-mediated lympholysis (1-3). In the current study we have demonstrated the capacity of leukocytes from 73% of midtrimester fetal spleens to mediate ADCC against HSV type I-infected target cells sensitized by anti-HSV antibody. This finding has relevance to both the mechanisms of fetal immune protection in general and specifically against HSV infection. Because n o correlation existed between the presence and level of ADCC activity and the gestational age within the 17-24 wk range of acquired specimens, the presence of ADCC activity does not seem to be associated with more advanced gestational ages within the midtrimester. However, this finding does not preclude the activity being dependent on the development or maturation of immune cells/factors because the activity may vary among fetuses within this gestational age range. The capacity for ADCC activity in the fetus may also depend on external factors, such as microbial antigenic exposure of the fetus. It is well known, for example, that certain viruses are capable of entering the fetal circulation transplacentally very early in gestation.
The passive acquisition of maternal IgG has to a large extent been credited for the immune defense against microbial invasion of the fetal compartment. The exact mechanisms by which maternal antibody provides this defense have not been described. Although the formation of antigen-antibody complexes or viral neutralization may play a role, passively acquired antibody should also be capable of mediating ADCC activity if adequate numbers ofeffector cells capable of ADCC are present. This may be particularly relevant to fetal protection against HSV or other viral infection where 1st or 2nd trimester fetal exposure to virus may be seen without subsequent signs of neonatal infection. Indeed, apparently 5% of neonatal human immunodeficiency virus is congenital (i.c., acquired it1 rttcro) (9) . Because neonatal human immunodeficiency virus is not always lethal, some fetal defense mechanism must be in effect.
In the blood of adults, the effector cells responsible for ADCC to HSV-infected cells include Fc receptor-positive polymorphonuclear leukocytes, non-T cell, non-B cell lymphocytes (natural killer cells) and Fc receptor-positive monocyte-macrophages (8, 10) . These cells have been further characterized by their plastic adherence and latex sensitivity. The two populations involved are the nonadherent, latex-resistant lymphocytes and the plastic adherent latex-sensitive macrophages (8) . It has further been shown that the lymphocyte effector cells require less antibody and mediate ADCC more rapidly than monocyte-macrophage effector cells (8) . Studies have revealed that ADCC activity in the human neonate may be blunted compared with the adult response. The ability of human cord blood mononuclear cells to mediate anti-HSV ADCC was shown to be significantly lower than that ofadult leukocytes (6, 7) . Although the neonatal ADCC response did not reach the magnitude of the adult, significant ADCC activity did occur. In one study in which a small number of adherent and nonadherent cell populations were studied separately, neither population of cells showed significantly lower ADCC than did adult cells ( I I). In the present study, fetal spleen cell ADCC activity was present in 73% of fetuses tested between 17 and 24 wk; however, the activity was significantly less than adult PBMC. Unfortunately, effector function of cells from adult spleen could not be obtained, precluding another control comparison.
When plastic adherent cells were removed from fetal cells, ADCC activity persisted at levels similar to whole spleen preparations. Latex beads have been shown to specifically inhibit macrophage ADCC. After exposure to latex beads, nonadherent fetal spleen cells exhibited a significant decrease in ADCC activity, unlike that response seen with adult nonadherent cells. Latex treatment did reduce the ADCC of unseparated cells from both fetuses and adults, probably because of its effect on the monocyte-macrophage population present in both groups of cells. These data suggest the presence of a nonadherent, latex-sensitive population of fetal ADCC effector cells. We conclude from these findings that fetal spleen monocyte-macrophage cells may lack the ability to efficiently adhere to plastic. This conclusion is further supported by the paucity of adherent cells recoverable after plastic adherence. An alternative, less likely, conclusion is that a unique cell population of fetal spleen cells exists characterized by latex sensitivity but not of the monocyte-macrophage lineage.
Although fetal spleen cells did not bind fluorescent-labeled MAb as well as adult PBMC, FACS analysis did reveal 36% CD3(+) staining for whole fetal spleen preparations, which is consistent with the one previous report on fetal spleen cells (12) . Because the absence of cells from the monocyte-macrophage cell line should be reflected in increased percentages of CD3(+) cells in the nonadherent population, an unexpected finding was that only 3 1 % of nonadherent fetal spleen cells were CD3(+). Thus. either the nonadherent population contains a significant number of CD,(-) lymphocytes capable of mediating ADCC activity as seen in adult PBMC (CDI6(+), CD56(+), CD3(-) cells or CD56 "bright," CDI6(-), CD3(-) cells), or fetal cells of the monocytemacrophage line do not effectively adhere ( 13) . Lanier ct al. ( 13) found that in adult PBMC most CD56(+) lymphocytes mediating non-MHC-restricted cytotoxicity against natural killer-sensitive tumor cells (K562) were either CD3(-)/CDl,(+) or CD,(+)/ CDI6(-). The paucity of nonadherent fetal spleen cells expressing either CDI6 (6.8%) or CD56 (10.4%) in this study further supports the hypothesis that a nonadherent population of monocytemacrophage-derived cells capable of mediating ADCC activity are present in the midtrimester human fetus. Because the fetal spleen cells had poor affinity for monocyte-specific (Leu-MI) fluorescent-labeled MAb, this hypothesis could not be confirmed definitively on the basis of FACS analysis alone.
Although Ig levels in the fetus are not as high as those of adults until the 3rd trimester, Ig transport begins in the 2nd to 3rd mo of gestation (14) . Along with intact ADCC effector function, this transport should allow for ADCC to be one of the defense mechanisms of the fetus. Further analysis of fetal effector cell mechanisms and response to other pathogens may clarify the role of ADCC in the fetus.
